Screener
Revvity RVTY Diagnostics — Segment research and development expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept revv:SegmentResearchAndDevelopmentExpenses.
The source filing: Revvity’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000031791-26-000019
| Line item | April 5, 2026 / Life Sciences | April 5, 2026 / Diagnostics | April 5, 2026 / Total | March 30, 2025 / Life Sciences | March 30, 2025 / Diagnostics | March 30, 2025 / Total |
|---|---|---|---|---|---|---|
| Segment revenue | $361,845 | $349,273 | $711,118 | $340,395 | $324,367 | $664,762 |
| Segment cost of revenue | 131,574 | 156,753 | 119,321 | 135,190 | ||
| Segment selling, general and administrative expenses | 94,668 | 90,192 | 87,094 | 89,891 | ||
| Segment research and development expenses | 31,624 | 26,206 | 28,269 | 25,271 | ||
| Segment operating income | $103,979 | $76,122 | 180,101 | $105,711 | $74,015 | 179,726 |
| Corporate expenses | (12,247) | (9,815) | ||||
| Amortization of intangible assets | (85,081) | (82,700) | ||||
| Purchase accounting adjustments | (141) | 177 |
Item 1.Unaudited Financial Statements
FAQ
- What is Revvity's diagnostics — segment research and development expenses?
- Revvity (RVTY) reported diagnostics — segment research and development expenses of $26.21M in Q1 2026.
- How has Revvity's diagnostics — segment research and development expenses changed year-over-year?
- Revvity's diagnostics — segment research and development expenses increased by 3.7% year-over-year, from $25.27M to $26.21M.
- What is the long-term trend for Revvity's diagnostics — segment research and development expenses?
- Over 3 years (2022 to 2025), Revvity's diagnostics — segment research and development expenses has grown at a -6.9% compound annual growth rate (CAGR), from $128.16M to $103.58M.
- What does diagnostics — segment research and development expenses mean?
- Represents the investment made by the diagnostics segment into the discovery, design, and development of new products, tests, and technologies. This is a critical indicator of the segment's commitment to long-term innovation and future revenue pipelines.
Ask your AI about Revvity's diagnostics — segment research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude